- Report
- July 2022
- 864 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- July 2022
- 68 Pages
Global
From €3097EUR$3,495USD£2,667GBP
- Report
- April 2022
- 204 Pages
Global
From €4431EUR$5,000USD£3,816GBP
- Clinical Trials
- December 2021
- 99 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Clinical Trials
- September 2021
- 213 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Clinical Trials
- February 2021
- 263 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- December 2019
- 63 Pages
Global
From €3540EUR$3,995USD£3,049GBP
- Report
- April 2023
- 78 Pages
Global
From €3097EUR$3,495USD£2,667GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €13288EUR$14,995USD£11,444GBP
- Report
- May 2022
- 208 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- May 2022
- 471 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- March 2022
- 1284 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Clinical Trials
- November 2021
- 929 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Clinical Trials
- November 2021
- 259 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Clinical Trials
- August 2021
- 276 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- September 2020
- 124 Pages
Global
From €9743EUR$10,995USD£8,391GBP
- Report
- December 2019
- 190 Pages
Global
From €13288EUR$14,995USD£11,444GBP
- Report
- July 2018
- 50 Pages
Global
From €3540EUR$3,995USD£3,049GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$4,231USD£3,120GBP
- Report
- February 2024
- 81 Pages
Global
From €3500EUR$4,231USD£3,120GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more